ARDX: Ardelyx Inc

ARDX新闻

• 12:15 Ardelyx Stock: The Market Is Right To Discount This Revenue Growth (NASDAQ:ARDX)
• 11:32 Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?
• 02:01 Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call Transcript
• 22:25 Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates
• 22:00 Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key Metrics
• 14:00 Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
• 14:00 Will Ardelyx (ARDX) Report Negative Earnings Next Week? What You Should Know
• 20:04 Leerink Partners重申Ardelyx股票评级,看好管线进展
• 20:01 Leerink Partners reiterates Ardelyx stock rating on pipeline progress
• 01:38 Ardelyx在Leerink会议上展示战略增长与管线重点
• 01:36 Ardelyx at Leerink Conference: Strategic Growth and Pipeline Focus
• 02:23 Ardelyx董事David Mott买入价值194万美元股票
• 02:22 Ardelrx director David Mott buys $1.94m in shares
• 02:05 Ardelyx (ARDX)首席技术运营官Bishop出售价值18,586美元的股票
• 02:05 Ardelyx高级副总裁Reilly出售2.9万美元股票以支付税务义务
• 02:04 Ardelrx (ARDX) chief technical operations officer Bishop sells shares worth $18,586
• 02:04 Ardelyx SVP Reilly sells $29k in shares to cover tax obligations
• 01:58 Ardelyx首席患者官Laura Williams出售ARDX股票,价值47,803美元